All In Biotech

Free tool

FAERS Monitor: Xyrem

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021196 or its brand name (Xyrem, Sodium Oxybate). Reports on generic versions are filed under their own applications.

Reports

62,191

Serious

32,274

52% of reports

Hospitalization

7,512

Death reported

941

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea4,303
  • anxiety3,664
  • somnolence3,187
  • depression3,032
  • headache2,931
  • feeling abnormal2,899
  • condition aggravated2,798
  • weight decreased2,785
  • fatigue2,672
  • dizziness2,640
  • insomnia2,567
  • sleep apnoea syndrome2,550
  • fall2,466
  • pre-existing condition improved2,218
  • drug ineffective2,181

Reports by year received

View as table
YearReports
200445
200530
200653
2007102
2008138
2009217
2010328
2011533
2012909
2013921
20141,831
201511,443
201619,535
20175,544
20184,530
20193,963
20203,142
20212,958
20222,041
20231,876
20241,124
2025508
2026420

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,968 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pre-existing condition improvedSignal2,218185.7176.5262,833
sleep apnoea syndromeSignal2,55052.049.9110,575
somnolenceSignal3,1875.45.211,419
depressionSignal3,0324.64.48,385
anxietySignal3,6644.44.39,622
feeling abnormalSignal2,8994.14.06,866
weight decreasedSignal2,7853.43.34,726
insomniaSignal2,5673.33.24,082
condition aggravatedSignal2,7983.13.04,080
fallSignal2,4662.52.42,273
nausea4,3031.81.81,715
dizziness2,6401.81.7945
headache2,9311.61.5646
fatigue2,6721.21.162
drug ineffective2,1810.60.5808

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.